Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for MEROPENEM

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 23
  • 0 comments

Labeling changes approved for BROOKS STERISCIENCE. Active ingredient: MEROPENEM. Decision date: 12/11/2025

Comment Full text

FDA approves LEROCHOL from LIB THERAPEUTICS, INC.

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 22
  • 0 comments

Final approval of BLA #BLA #761427 for LERODALCIBEP-LIGA. Decision date: 12/12/2025

Comment Full text

FDA approves LOPINAVIR AND RITONAVIR from MICRO LABS

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 20
  • 0 comments

Final approval of ANDA #ANDA #214696 for LOPINAVIR; RITONAVIR. Decision date: 12/11/2025

Comment Full text

FDA expands indications for BLUJEPA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 11
  • 0 comments

GLAXOSMITHKLINE receives approval for new indications. Submission: SUPPL-1. Decision date: 12/11/2025

Comment Full text

FDA approves NOREPINEPHRINE BITARTRATE from MSN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 22
  • 0 comments

Final approval of ANDA #ANDA #218595 for NOREPINEPHRINE BITARTRATE. Decision date: 12/11/2025

Comment Full text

FDA regulatory update for STEQEYMA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 12
  • 0 comments

Administrative update #SUPPL-7 for CELLTRION, INC.. Status: Approval. Decision date: 12/12/2025

Comment Full text

FDA updates labeling for XTANDI

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 8
  • 0 comments

Labeling changes approved for ASTELLAS. Active ingredient: ENZALUTAMIDE. Decision date: 12/11/2025

Comment Full text

FDA updates labeling for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 21
  • 0 comments

Labeling changes approved for WATSON LABS. Active ingredient: NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA approves OCTREOTIDE ACETATE from MYLAN LABS LTD

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 21
  • 0 comments

Final approval of ANDA #ANDA #216589 for OCTREOTIDE ACETATE. Decision date: 12/12/2025

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 23
  • 0 comments

Labeling changes approved for ALKEM LABS LTD. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 12/12/2025

Comment Full text
  • Previous
  • 35
  • 36
  • 37
  • 38
  • 39
  • Next

Search

News categories

  • Technical Exchange News(11257)
  • Event(2616)
  • SEC News(198392)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131558)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin